Imiquimod: a novel treatment for lentigo maligna
Top Cited Papers
- 1 October 2000
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 143 (4) , 843-845
- https://doi.org/10.1046/j.1365-2133.2000.03787.x
Abstract
Lentigo maligna is the in situ phase of lentigo maligna melanoma, and if left untreated it may progress to invasive melanoma. It most commonly occurs on the exposed sites of the face and neck of midd...Keywords
This publication has 16 references indexed in Scilit:
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999
- Cytokine Induction in Hairless Mouse and Rat Skin After Topical Application of the Immune Response Modifiers Imiquimod and S-28463Journal of Investigative Dermatology, 1998
- Safety and efficacy of imiquimod 5% cream for the treatment of bowen's diseaseJournal of Dermatological Science, 1998
- Treatment of lentigo malignaAustralasian Journal of Dermatology, 1997
- Treatment of Lentigo Maligna With the Carbon Dioxide LaserArchives of Dermatology, 1995
- Successful treatment of lentigo maligna and lentigo maligna melanoma with mohs' micrographic surgery aided by rush permanent sectionsCancer, 1994
- Argon laser treatment of lentigo malignaJournal of the American Academy of Dermatology, 1984
- Treatment of Lentigo Maligna and Lentigo Maligna MelanomaThe Journal of Dermatologic Surgery and Oncology, 1979
- Sensitivity of pigmented mucosa and skin to freezing injuryCryobiology, 1979
- Melanotic freckle of hutchinsonCancer, 1968